文献速递胃肠动力与功能性疾病

便秘的负担:超越排便次数

Burden of Constipation: Looking Beyond Bowel Movements.
PubMed 文献 · Am J Gastroenterol · 2022-01-01

慢性特发性便秘(CIC)与便秘型肠易激综合征(IBS-C)带来显著社会和经济负担。患者与医疗保健提供者(HCP)对症状的认知存在差异,患者更多报告接受并控制症状。仅三分之一患者正式就诊,不足半数用药且多为非处方药,仅五分之一就诊者认为症状管理良好。

要点

  • 患者与HCP对CIC/IBS-C症状认知存在差异。
  • 仅三分之一CIC/IBS-C患者正式就诊。
  • 不足半数用药,且多为非处方药。

核心结论

  • 许多CIC和IBS-C患者仍管理不充分并受到不当影响,导致这些疾病的高社会和经济负担。

研究设计与样本

  • 原文未报告研究设计。

主要发现

  • 相比HCP对患者症状的认知,更大比例患者报告接受并感觉能控制其CIC或IBS-C症状。
  • 仅三分之一CIC或IBS-C个体就便秘正式咨询HCP。
  • 不足半数患者用药,且通常为非处方疗法而非处方疗法。
  • 就诊者中仅五分之一感觉其便秘症状管理良好。
  • 就便秘咨询HCP存在明显性别和文化差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) are associated with significant social and economic burdens. To address these burdens, a deeper understanding of their root causes is required. A discrepancy exists between patients' and healthcare providers' (HCPs) perceptions of constipation symptoms and the impact of symptoms associated with CIC and IBS-C. Compared with the HCPs' perceptions of patients' symptoms, a greater percentage of patients report acceptance and feeling in control of their CIC or IBS-C symptoms. Unfortunately, only one-third of individuals with CIC or IBS-C formally consult an HCP about their constipation. Fewer than half take medications, and these are generally over-the-counter therapies rather than prescription therapies. For those who seek help, only one-fifth feel that their constipation symptoms are well managed. Notable sex and cultural differences exist regarding individuals consulting their HCP about constipation. Many individuals with CIC and IBS-C remain inadequately managed and unduly affected, contributing to the high social and economic burden of these conditions.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Harris LA, Chang CH. Burden of Constipation: Looking Beyond Bowel Movements. Am J Gastroenterol. 2022. PMID: 35354769. doi:10.14309/ajg.0000000000001708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。